Is coverage of S. aureus necessary in cellulitis/erysipelas? A literature review.

Karakonstantis, Stamatis

Karakonstantis, Stamatis.

Affiliation

Karakonstantis S; Infectious Diseases Unit, School of Medicine, University of Crete, Voutes, Heraklion, Postal code 71110, Greece. stamatiskarakonstantis@gmail.com.

Infection ; 48(2): 183-191, 2020 Apr.

Article in En | MEDLINE | ID: mdl-31845187

Subject(s)

Anti-Bacterial Agents/therapeutic use; Cellulitis/drug therapy; Erysipelas/drug therapy; Staphylococcal Infections/drug therapy; Cellulitis/microbiology; Disease Management; Erysipelas/microbiology; Humans; Methicillin-Resistant Staphylococcus aureus/physiology; Staphylococcal Infections/microbiology; Staphylococcus aureus/physiology; Streptococcus/physiology

Key words

Cellulitis; Erysipelas; MRSA; MSSA; Penicillin; Staphylococcus aureus; Treatment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Cellulitis / Erysipelas / Anti-Bacterial Agents Type of study: Clinical_trials / Guideline / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Infection Year: 2020 Document type: Article Affiliation country: Greece Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google